VistaGen Therapeutics Correlations

VTGN Stock  USD 2.94  0.08  2.80%   
The current 90-days correlation between VistaGen Therapeutics and Entera Bio is 0.2 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VistaGen Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VistaGen Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

VistaGen Therapeutics Correlation With Market

Average diversification

The correlation between VistaGen Therapeutics and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VistaGen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in VistaGen Stock, please use our How to Invest in VistaGen Therapeutics guide.

Moving together with VistaGen Stock

  0.67PFE Pfizer Inc Earnings Call This WeekPairCorr
  0.68INKT Mink TherapeuticsPairCorr

Moving against VistaGen Stock

  0.35BMY Bristol Myers Squibb Earnings Call This WeekPairCorr
  0.44SGMO Sangamo Therapeutics Buyout TrendPairCorr
  0.35PTCT PTC TherapeuticsPairCorr
  0.4DNOW Now IncPairCorr
  0.38TGNA Tegna IncPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
HSTOTCON
TCONEFTR
BTTXTCON
TPSTHSTO
TPSTTCON
BTTXHSTO
  
High negative correlations   
HSTOICVX
TCONICVX
ENTXACIU
TPSTICVX
BTTXICVX
ICVXEFTR

Risk-Adjusted Indicators

There is a big difference between VistaGen Stock performing well and VistaGen Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze VistaGen Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SYBX  1.83  0.01 (0.04) 0.02  2.04 
 4.17 
 11.40 
EFTR  7.57 (4.61) 0.00 (7.49) 0.00 
 8.70 
 88.91 
GRTX  2.93 (0.06) 0.00 (0.07) 0.00 
 7.31 
 18.16 
ICVX  4.87  1.05  0.18 (2.04) 4.56 
 10.22 
 38.57 
ACIU  2.30 (0.22) 0.00 (0.21) 0.00 
 5.63 
 23.56 
TCON  6.84 (1.90) 0.00 (2.63) 0.00 
 19.59 
 52.05 
HSTO  5.31 (1.19) 0.00  0.48  0.00 
 10.80 
 93.31 
ENTX  3.29  0.51  0.14 (0.95) 2.55 
 9.38 
 27.10 
TPST  3.16 (0.31) 0.00 (0.10) 0.00 
 4.55 
 24.26 
BTTX  4.55 (0.82) 0.00 (1.64) 0.00 
 12.64 
 36.53 

VistaGen Therapeutics Corporate Management

CPA CPAChief OfficerProfile
Michelle WellingtonVice CommunicationsProfile
Cynthia CPAChief OfficerProfile
Mark GinskiManufacturing ChemistryProfile
Erik MDSenior PharmacovigilanceProfile
JD EsqChief OfficerProfile
Joshua MBASr OperationsProfile